Found: 1
Select item for more details and to access through your institution.
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity.
- Published in:
- Cancer Communications, 2024, v. 44, n. 8, p. 884, doi. 10.1002/cac2.12589
- By:
- Publication type:
- Article